CXCL10 and viral infectious disease: Systematic comparison of medication use and follow-up analyses identified a subset of chemotherapeutic drugs associated with reduced nasopharyngeal CXCL10 response to viral respiratory infection, suggesting that CXCL10 may be a less sensitive indicator of viral infection for patients on these medications.